News
$Tempest Therapeutics (TPST.US)$ Reuters· 2 mins ago
Rempest Announces Agreement With Roche to Support Advancement of Amezalpat Combination Therapy Into First-Line Hepatocellular Carcinoma Pivotal Trial
Rempest Announces Agreement With Roche to Support Advancement of Amezalpat Combination Therapy Into First-Line Hepatocellular Carcinoma Pivotal Trial
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
